Systemic treatment of cholangiocellular carcinoma in Germany – Results from the prospective national intersectoral cohort study JADE 10. November 2023 Freiberg-Richter J, Uhlig J, von der Heyde E, Schröder J, Pereira PL, Hofmann WP, et al. Onco Targets Ther. 2023;46 (Suppl.5)(V309):354 Link Testing for and frequency of EGFR and ALK alterations in patients with early and locally advanced non-small cell lung cancer in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315) Eberhardt WEE, Thomas M, Stuschke M, De Wit M, Seese B, Spring L, Andres-Pons A, Jaenicke M, Vahtrik O, Ludwig P, Hipper A, Hoffknecht P,… Weiterlesen Use of newly approved drugs for patients with early breast cancer (stage I-III) in Germany – data of the prospective, intersectoral research platform OPAL Zahn M.-O., Decker T., Thoma M., Nusch A., Müller L., Zaiss M., Beurer B., Buss-Steidle R., Kruggel L., Lennartz C., Jänicke M., Gratzke K., Harbeck… Weiterlesen